Study of Efficacy and Safety of Fingolimod (Gilenya) 0.5 mg in Chinese Patients With Relapsing Multiple Sclerosis (RMS) Patients
Clinical trial NCT04667949 · COMPLETED
Trial details
- NCT number
- NCT04667949
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-20
- Primary completion
- 2025-03-25
- Enrollment
- 98
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.